Coleman Mark

Coleman Mark is listed in filings as Director at Axsome Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 10, 2026, including sale activity. Recent filings connect the profile to Axsome Therapeutics, Inc. (AXSM). The current snapshot covers public activity from Jun 9, 2026 to Jun 10, 2026. Reported amounts are shown as $160.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.